0001246360-17-000452.txt : 20170206
0001246360-17-000452.hdr.sgml : 20170206
20170206172111
ACCESSION NUMBER: 0001246360-17-000452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170203
FILED AS OF DATE: 20170206
DATE AS OF CHANGE: 20170206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NxStage Medical, Inc.
CENTRAL INDEX KEY: 0001333170
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043454702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
BUSINESS PHONE: 978-687-4700
MAIL ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Robert S.
CENTRAL INDEX KEY: 0001382096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51567
FILM NUMBER: 17576484
MAIL ADDRESS:
STREET 1: NXSTAGE MEDICAL INC
STREET 2: 439 SOUTH UNION STREET 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
FORMER NAME:
FORMER CONFORMED NAME: Brown Robert
DATE OF NAME CHANGE: 20061127
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2017-02-03
false
0001333170
NxStage Medical, Inc.
NXTM
0001382096
Brown Robert S.
350 MERRIMACK STREET
LAWRENCE
MA
01843
false
true
false
false
President, NxStage Kidney Care
Common Stock
2017-02-03
4
M
false
13000
14.66
A
42217
D
Common Stock
2017-02-03
4
S
false
13000
26.77
D
29217
D
Common Stock
2017-02-06
4
S
false
3283
27.29
D
25934
D
Stock Option (Right to Buy)
14.66
2017-02-03
4
M
false
13000
0
D
2014-04-10
2024-03-09
Common Stock
13000
21958
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $26.58 to $27.04, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $27.20 to $27.43, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
Aras Lapinskas, attorney-in-fact for Robert Brown
2017-02-06